Profile
Dana Lee is currently Vice President-Drug Safety at Pharmacyclics LLC since 2013.
Formerly, Dr. Lee was Senior Director-Pharmacovigilance Division at Amylin Pharmaceuticals, Inc. in 2011 and Vice President-Medical Affairs at Mast Therapeutics, Inc. in 2012.
Dr. Lee earned a doctorate from The University of California, San Francisco.
Dana Lee active positions
| Companies | Position | Start |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 2013-01-31 |
Former positions of Dana Lee
| Companies | Position | End |
|---|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Chief Tech/Sci/R&D Officer | 2011-12-31 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | 2010-12-31 |
Training of Dana Lee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Dana Lee
















